Specific expression of half-tRNA in cancers

    公开(公告)号:US10662480B2

    公开(公告)日:2020-05-26

    申请号:US15116452

    申请日:2015-02-04

    Abstract: The present invention relates to systems, devices and methods for diagnosing cancer. In various embodiments, the present invention provides a method for quantifying a 5′-htRNA; a method for quantifying a 3′-htRNA; a method for obtaining a DNA library of 5′-htRNAs and a DNA library of 5′-htRNAs obtained therefrom; and a method for obtaining a DNA library of 3′-htRNAs and a DNA library of 3′-htRNAs obtained therefrom. The invention also teaches a method for determining the presence or absence of a cancer cell in a biological sample; a method of diagnosing cancer in a subject; and a method of prognosing cancer in a subject.

    SPECIFIC EXPRESSION OF HALF-TRNA IN CANCERS

    公开(公告)号:US20210355548A1

    公开(公告)日:2021-11-18

    申请号:US17313524

    申请日:2021-05-06

    Abstract: The present invention relates to systems, devices and methods for diagnosing cancer. In various embodiments, the present invention provides a method for performing sequencing of 5′-htRNA in an RNA sample including obtaining a DNA library of 5′-htRNA and sequencing the DNA library of 5′-htRNAs in the RNA sample. The invention also teaches a method for quantifying 5′-htRNA half molecules in an RNA sample including (a) treating an RNA sample containing 5′-htRNAs half molecules having a 3′ cyclic phosphate with a T4 polynucleotide kinase to form 3′-dephosphrylated 5′-tRNA halves, (b) 3′-AD ligating the 3′-dephosphrylated 5′-tRNA halves to form ligated RNA products, and (c) quantifying the ligated RNA products by RT-qPCR using a plurality of target primers and probes configured to simultaneously quantify at least two cP-containing 5′-tRNA half species. The treating of step (a) is simultaneously performed as one step in a single tube with the 3′-AD ligating of step (b).

    Specific expression of half-tRNA in cancers

    公开(公告)号:US11001897B2

    公开(公告)日:2021-05-11

    申请号:US16802107

    申请日:2020-02-26

    Abstract: The present invention relates to systems, devices and methods for diagnosing cancer. In various embodiments, the present invention provides a method for quantifying a 5′-htRNA; a method for quantifying a 3′-htRNA; a method for obtaining a DNA library of 5′-htRNAs and a DNA library of 5′-htRNAs obtained therefrom; and a method for obtaining a DNA library of 3′-htRNAs and a DNA library of 3′-htRNAs obtained therefrom. The invention also teaches a method for determining the presence or absence of a cancer cell in a biological sample; a method of diagnosing cancer in a subject; and a method of prognosing cancer in a subject.

    Dumbbell-PCR: a method to quantify specific small RNA variants with a single nucleotide resolution at terminal sequences

    公开(公告)号:US11535888B2

    公开(公告)日:2022-12-27

    申请号:US15754194

    申请日:2016-08-22

    Abstract: A method for specifically and efficiently quantifying the expression of targeted RNA variants with specific terminal sequences suitable to identify multiple isoforms bearing complex heterogeneity in terminal sequences by hybridizing a 5′-Dbs-adapter to the 5′-end of target RNAs, wherein the 5′-Dbs-adapter has a stem-loop structure whose protruding 5′-end base-pairs with the 5′-end of target RNAs, and wherein the loop region of 5′-Dbs-adapter contains a base-lacking spacer which will terminate reverse transcription in a subsequent step; hybridizing a 3′Db-adapter to the 3′-end of target RNAs, wherein the 3′-Db-adapter has a stem-loop structure whose protruding 3′-end base-pairs with the 3′-end of target RNAs; ligating both adapters with target RNAs by RN12 ligation to form a “dumbbell-like” structure; and, amplifying and quantifying the ligation product by RT-PCR.

    SPECIFIC EXPRESSION OF HALF-TRNA IN CANCERS
    5.
    发明申请

    公开(公告)号:US20170314076A1

    公开(公告)日:2017-11-02

    申请号:US15116452

    申请日:2015-02-04

    Abstract: The present invention relates to systems, devices and methods for diagnosing cancer. In various embodiments, the present invention provides a method for quantifying a 5′-htRNA; a method for quantifying a 3′-htRNA; a method for obtaining a DNA library of 5′-htRNAs and a DNA library of 5′-htRNAs obtained therefrom; and a method for obtaining a DNA library of 3′-htRNAs and a DNA library of 3′-htRNAs obtained therefrom. The invention also teaches a method for determining the presence or absence of a cancer cell in a biological sample; a method of diagnosing cancer in a subject; and a method of prognosing cancer in a subject.

Patent Agency Ranking